Need Help?
If you have technical issues or a general question about the event, contact us at 877‐573‐9971, Mon ‐ Fri, 8 a.m. to 5 p.m. PT, or events@pancan.org.
Contact PanCAN Patient Services
for answers to any questions you have about pancreatic cancer, treatment options and more. Our expert case managers are here from 7 a.m. to 5 p.m. PT, Monday through Friday, to help.
FEATURING

Julie M. Fleshman, JD, MBA
PanCAN President and CEO, leading the way for more than two decades in PanCAN’s approach to take bold steps to make progress in pancreatic cancer research and improve patient outcomes

Lynn Matrisian, PhD, MBA
PanCAN Chief Science Officer, leading research and clinical initiatives, including the PanCAN Early Detection Initiative, PanCAN’s Research Grants Program and more

Vincent Picozzi, MD
Oncologist, Virginia Mason Medical Center, Division of Hematology/Oncology; Director, Pancreas Center of Excellence; PanCAN Precision Promise Clinical Trial Consortium Chair and Steering Committee member; member, PanCAN Scientific & Medical Advisory Board

Suresh T. Chari, MD
Professor, Department of Gastroenterology Hepatology and Nutrition, Division of Internal Medicine, MD Anderson Cancer Center; PanCAN Early Detection Initiative Principal Investigator; member, PanCAN Scientific & Medical Advisory Board

Linda E. Amuso
Senior Partner, Human Capital Solutions for Aon, based in San Francisco; former caregiver for her wife, whom she lost to pancreatic cancer in 2016; proud supporter of PanCAN research and clinical initiatives